Methazolamide
Methazolamide is a carbonic anhydrase inhibitor used to reduce elevated intraocular pressure in patients with open-angle glaucoma and, in selected cases, other forms of glaucoma. It works by inhibiting carbonic anhydrase in the ciliary processes, reducing aqueous humour production and lowering pressure inside the eye. It is commonly available as oral tablets. Common side effects include tingling sensations, fatigue, dizziness, altered taste, nausea, and increased urination. Important precautions include monitoring kidney and liver function, serum electrolytes, and blood counts, as well as avoiding use in patients with significant electrolyte disturbances or certain severe kidney or liver conditions. Methazolamide should be taken under medical supervision, with regular eye examinations to assess treatment response.
Methazolamide was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Methazolamide, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Methazolamide from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Methazolamide, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
